benefits of glp-1 drugs 8 GLP‑1's Beyond Weight Loss GLP-1 Medication for Weight Loss:

Ozempic is not FDA-approved for the treatment of prediabetes (e.g., HbA1c or A1C of 5.76.4%)

Tirzepatide Research# SURPASS program (Type 2 diabetes): Five Phase 3 trials demonstrating superior HbA1c reduction compared to insulin glargine, semaglutide, and insulin degludec SURMOUNT program (Obesity): Phase 3 trials showing up to 20.9% weight loss at 72 weeks FDA approvals : Mounjaro (May 2022) for T2D

These drug combinations have the same efficacy for people with diabetes to effectively manage their blood sugar levels [39]

The program is covering medications only for people who meet the definition of obesity, not for those who are overweight, Moore said